Inhibition |
miR-17-5p |
up-regulated |
Beclin 1 |
radiosensitivity |
U87 (glioblastoma) |
59 |
miR-21 |
up-regulated |
PTEN |
radiosensitivity |
Hela, Siha(cervical cancer) |
168 |
miR-23b |
downregulated |
ATG12 |
radiosensitivity |
BxPC3, PANC-1 (pancreatic cancer) |
139 |
miR-31 |
downregulated |
Beclin 1, ATG, DRAM |
radiosensitivity |
Primary cultured cells (colorectal cancer) |
169 |
miR-93 |
up-regulated |
Beclin 1, ATG5, ATG4B, SQSTM1 |
radiosensitivity |
U87 (glioblastoma) |
170 |
miR-101 |
downregulated |
STMN1 |
radioresistance |
CNE-2, 5-8F (nasopharyngeal carcinoma) |
171 |
miR-129-5p |
downregulated |
HMGB1 |
radiosensitivity |
MCF-7, MDA-MB-231 , BT549, BT474 (breast cancer) |
43 |
miR-183-5p |
up-regulated |
ATG5 |
radiosensitivity |
Caco-2 (colon cancer) |
172 |
miR-200c |
downregulated |
UBQLN1 |
radiosensitivity |
MDA-MB-231, BT549 (breast cacer) |
173 |
miR-214 |
downregulated |
ATG12 |
radiosensitivity |
SW480, HCT116 (colorectal cancer) |
174 |
miR-216b |
up-regulated |
Beclin 1 |
radioresistance |
PANC-1 (pancreatic cancer) |
175 |
miR-450a-5p |
downregulated |
DUSP10 |
radioresistance |
ECA (esophageal cancer) |
176 |
Activation |
miR-138-5p |
downregulated |
EIF4EBP1 |
radiosensitivity |
HONE1, HK1 (nasopharyngeal carcinoma) |
141 |
miR-301a/b |
up-regulated |
NDRG2 |
radioresistance |
LNCaP (prostate cancer) |
142 |
miR-1246 |
up-regulated |
mTOR |
radioresistance |
A549, PC9 (lung cancer) |
177 |
miR-4673 |
up-regulated |
CDK-18 |
radioresistance |
SKBR3 (breast cancer) |
178 |